Increased plasma levels of inflammatory mediators, e.g., C-reactive protein, leukocytes or interleukin 6 (IL-6), have been shown to predict the development of insulin resistance and type 2 diabetes [11]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.